Compare ALEMBIC PHARMA with Dr. Reddys - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs DR. REDDYS LAB - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA DR. REDDYS LAB ALEMBIC PHARMA/
DR. REDDYS LAB
 
P/E (TTM) x 28.9 28.3 102.1% View Chart
P/BV x 2.9 4.1 70.1% View Chart
Dividend Yield % 1.8 0.6 322.3%  

Financials

 ALEMBIC PHARMA   DR. REDDYS LAB
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-21
DR. REDDYS LAB
Mar-21
ALEMBIC PHARMA/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs1,1505,515 20.9%   
Low Rs5273,028 17.4%   
Sales per share (Unadj.) Rs274.41,145.4 24.0%  
Earnings per share (Unadj.) Rs56.7114.5 49.5%  
Cash flow per share (Unadj.) Rs66.0188.4 35.1%  
Dividends per share (Unadj.) Rs14.0025.00 56.0%  
Avg Dividend yield %1.70.6 285.2%  
Book value per share (Unadj.) Rs260.91,053.2 24.8%  
Shares outstanding (eoy) m196.56166.30 118.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.13.7 82.0%   
Avg P/E ratio x14.837.3 39.6%  
P/CF ratio (eoy) x12.722.7 56.0%  
Price / Book Value ratio x3.24.1 79.3%  
Dividend payout %24.721.8 113.0%   
Avg Mkt Cap Rs m164,818710,289 23.2%   
No. of employees `000NANA-   
Total wages/salary Rs m10,51236,299 29.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m53,931190,475 28.3%  
Other income Rs m8752,914 30.0%   
Total revenues Rs m54,806193,389 28.3%   
Gross profit Rs m14,80138,699 38.2%  
Depreciation Rs m1,83512,288 14.9%   
Interest Rs m160970 16.5%   
Profit before tax Rs m13,68128,355 48.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,5339,319 27.2%   
Profit after tax Rs m11,14819,036 58.6%  
Gross profit margin %27.420.3 135.1%  
Effective tax rate %18.532.9 56.3%   
Net profit margin %20.710.0 206.8%  
BALANCE SHEET DATA
Current assets Rs m25,779145,503 17.7%   
Current liabilities Rs m12,80881,038 15.8%   
Net working cap to sales %24.133.8 71.1%  
Current ratio x2.01.8 112.1%  
Inventory Days Days2361 38.3%  
Debtors Days Days295 2.5%  
Net fixed assets Rs m41,311109,979 37.6%   
Share capital Rs m393832 47.2%   
"Free" reserves Rs m50,883174,319 29.2%   
Net worth Rs m51,276175,151 29.3%   
Long term debt Rs m1,9996,299 31.7%   
Total assets Rs m67,090255,482 26.3%  
Interest coverage x86.430.2 285.8%   
Debt to equity ratio x00 108.4%  
Sales to assets ratio x0.80.7 107.8%   
Return on assets %16.97.8 215.2%  
Return on equity %21.710.9 200.0%  
Return on capital %26.016.2 160.8%  
Exports to sales %66.851.3 130.2%   
Imports to sales %12.718.1 70.2%   
Exports (fob) Rs m36,02097,699 36.9%   
Imports (cif) Rs m6,84534,420 19.9%   
Fx inflow Rs m36,02097,699 36.9%   
Fx outflow Rs m6,84534,420 19.9%   
Net fx Rs m29,17563,279 46.1%   
CASH FLOW
From Operations Rs m14,63435,703 41.0%  
From Investments Rs m-8,388-22,660 37.0%  
From Financial Activity Rs m-5,974-298 2,004.8%  
Net Cashflow Rs m26212,858 2.0%  

Share Holding

Indian Promoters % 69.1 26.7 258.6%  
Foreign collaborators % 0.5 0.0 -  
Indian inst/Mut Fund % 17.8 49.9 35.6%  
FIIs % 6.0 25.2 23.9%  
ADR/GDR % 0.0 11.2 -  
Free float % 30.4 62.1 49.0%  
Shareholders   106,437 263,803 40.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   CIPLA    SUN PHARMA    LUPIN    ZYDUS LIFESCIENCES    AUROBINDO PHARMA    



Today's Market

Sensex Ends 236 Points Lower, Nifty Falls Below 16,150; IT & FMCG Stocks Witness Selling(Closing)

Indian share markets ended on a negative note today as global cues remained weak.

Related Views on News

Dr Reddy's Net Profit Falls 76%. Company Declares 600% Dividend (Views On News)

May 19, 2022

During Q4, there were many changes to the products forming part of Dr Reddy's generics and proprietary products segments.

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

Why Divi's Lab Share Price is Falling (Views On News)

May 24, 2022

Here's why Divi's Lab's stock fell over 10% in two days.

More Views on News

Most Popular

2022's Best Performing Penny Stocks So Far...(Views On News)

Mar 2, 2022

We are just two months into 2022 and several penny stocks that we track have already surged 5x.

5 Debt Free Penny Stocks with Good Profitability to Watch Out for in 2022(Views On News)

Mar 16, 2022

Debt free penny stocks are vital when it's a question of portfolio diversification in a volatile market. They can potentially offer good profitability in the long run.

Penny Stocks to Buy and Hold Beyond 2022(Views On News)

Apr 6, 2022

A step-by-step method to pick the best penny stocks for the long term.

6 Penny Stocks that Could Be Hidden Bluechips. Take a Look...(Views On News)

Apr 13, 2022

These penny stocks can become future multibaggers. Watch out for them.

Adani Power vs Tata Power: Which Power Stock is Better?(Views On News)

Feb 28, 2022

Rising electricity consumption provides a lot of scope for growth. Which company has a better chance at capturing it?

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


May 24, 2022 03:31 PM

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA 8-QTR ANALYSIS

COMPARE ALEMBIC PHARMA WITH

MARKET STATS